Loading...
Loading...
Analysts at Piper Jaffray downgraded
Mirati Therapeutics, Inc. MRTX from Overweight to Neutral. The target price for Mirati Therapeutics has been lowered from $50 to $45. Mirati Therapeutics shares closed at $44.34 on Wednesday.
Analysts at Macquarie downgraded
StarzSTRZA from undefined to Neutral. Starz shares closed at $40.44 on Wednesday.
Analysts at UBS downgraded
Natural Resource Partners LPNRP from Neutral to Sell. The target price for Natural Resources is set to $2.50. Natural Resources shares closed at $2.97 on Wednesday.
BB&T Capital downgraded
Accuride CorporationACW to Hold. Accuride shares closed at $3.29 on Wednesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in